The most common form of stroke is an ischemic stroke, which occurs when a blood vessel that carries blood to the brain is blocked by a blood clot. Stroke is the leading cause of disability in adults and the second leading cause of death worldwide.
Effectiveness of stroke treatment was evaluated in the EXTEND-IA, a randomized clinical trial conducted at the Royal Melbourne Hospital by scientists from Australia and New Zealand.
In addition to standard treatment, i.e. Using tissue plasminogen activator (TPA) to dissolve blood clots, patients underwent a minimally invasive procedure to remove blood clots called stent thrombectomy.
Neurologist from Royal Melbourne Hospital – Dr. Bruce Campbell stated that the study showed a significant improvement in blood flow to the brain, which is of great importance in stroke recovery.
"In 89% of patients, blood flow to the brain was restored after using the clot removal procedure; the corresponding proportion of patients who underwent the standard clot resorption procedure alone was 34%."
With the combination of standard treatment and stent thrombectomy, 71% of patients returned to normal life (without stent thrombectomy, the percentage of recovered patients was 40%).
Specialists call such results amazing. This combined treatment, they say, provides recovery from even the most severe forms of stroke and significantly reduces the risk of disability.
When treating a stroke, it is very important to restore blood flow to the brain as soon as possible. A new method of treatment – stent thrombectomy – is a minimally invasive procedure performed through an angiogram: a small tube is inserted into an artery in the groin, from where it is sent to the brain to localize and remove the clot.
Source estet-portal.com
Share:
Add a comment